Cadwalader, Wickersham & Taft LLP Washington, NY Document Search Results (26)
Show: results per page
|Jury Rejects Chinese Vitamin C Maker’s Foreign Compulsion Defense|
Joseph J. Bial, Rocky T. Lee, Charles F. Rule; Cadwalader, Wickersham & Taft LLP;
March 18, 2013, previously published on March 15, 2013A jury has returned a verdict against vitamin C manufacturer Hebei Welcome Pharmaceutical and its parent, North China Pharmaceutical Group, for violating American antitrust law. In finding for the plaintiffs, the jury rejected the Chinese companies’ defense that their conduct had been...
|State Review Team Finds Financial Emergency in City of Detroit. What is Next for the City of Detroit?|
Mark C. Ellenberg, Stephen Grow, Tim Horner, Lary Stromfeld; Cadwalader, Wickersham & Taft LLP;
February 20, 2013, previously published on February 19, 2013On February 19, 2013, the six-person Review Team appointed by Michigan’s Governor to conduct a detailed financial review of the City of Detroit delivered its report to the Governor. The Report concludes that a financial emergency exists in the City.
|Criminal Antitrust Whistleblower Act Reintroduced|
Joseph J. Bial, Bradley J. Bondi, Samer Korkor, Anthony V. Nanni, Charles F. Rule; Cadwalader, Wickersham & Taft LLP;
February 12, 2013, previously published on February 8, 2013On January 22, 2013, Sens. Patrick Leahy (D-VT) and Chuck Grassley (R-IA) reintroduced legislation to the Senate Judiciary Committee that would extend whistleblower protections to employees who provide information to federal prosecutors in criminal antitrust investigations. If passed, the Criminal...
|“Worthless Services” Can Be Costly: Nursing Facilities Enter Into CIA and Financial Settlement to Resolve False Claims Act Suit Under “Worthless Services” Theory Over Alleged Quality Issues|
Jared L. Facher, Adam S. Lurie, Brian T. McGovern; Cadwalader, Wickersham & Taft LLP;
February 12, 2013, previously published on February 6, 2013With reform of the delivery and financing of health care at the federal and state level under way, quality of care has increasingly become a significant component of reimbursement for providers and managed care plans (e.g., “pay for performance” and quality incentive initiatives). At...
|HSR Thresholds Increased for 2013|
Andrew J. Forman, Ngoc Pham Hulbig, Jonathan S. Kanter, Charles F. Rule; Cadwalader, Wickersham & Taft LLP;
January 25, 2013, previously published on January 14, 2013The Federal Trade Commission’s (“FTC”) annual revisions to the dollar jurisdictional thresholds in the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), will become effective on February 11, 2013. These changes increase the dollar...
|The Japan Fair Trade Commission’s Report on Corporate|
Joseph J. Bial, Anthony V. Nanni, Charles F. Rule; Cadwalader, Wickersham & Taft LLP;
January 15, 2013, previously published on January 11, 2013The Japan Fair Trade Commission (JFTC) recently published a report titled “Survey on Corporate Compliance Efforts with the Antimonopoly Act (Summary).” The report comes at a time that Japanese corporations are facing greater scrutiny at home and abroad for anticompetitive conduct. In...
|FERC Grants CAISO Declaratory Order Request and Accepts Reliability|
Terence Healey, Kenneth W. Irvin, Danielle K. Schonback; Cadwalader, Wickersham & Taft LLP;
January 15, 2013, previously published on January 10, 2013On January 4, 2013, FERC granted a petition for declaratory order filed by the California Independent System Operator Corporation (“CAISO”) in late November asking FERC to find that consent by BE CA, LLC, a subsidiary of JP Morgan Ventures Energy Corporation (collectively, “JP...
|U.S. Department of Labor Proposes New Criteria for Which Entities Would Qualify as “Rating Agencies” in Connection with the Underwriter Exemptions|
Robert A. Davis, James Scott Frazier, Bronislaw E. Grala; Cadwalader, Wickersham & Taft LLP;
January 10, 2013, previously published on January 8, 2013On December 28, 2012, the U.S. Department of Labor (the “DOL”) published a proposed amendment to the so-called “Underwriter Exemptions,” which provide relief from certain of the prohibited transaction provisions of the Employee Retirement Income Security Act of 1974, as...
|CEOs and CFOs Beware: Court Endorses SEC's Aggressive Use of Section 304 of Sarbanes-Oxley to Clawback Compensation of Executives Who Did Not Engage in Misconduct|
Bradley J. Bondi, Emily J. Rockwood; Cadwalader, Wickersham & Taft LLP;
January 2, 2013, previously published on January 2, 2013Executive pay is under fire again. According to a recent district court decision in the Western District of Texas interpreting section 304 of the Sarbanes-Oxley Act of 2002, corporate executives could lose their bonuses and other incentive compensation if their company is required to revise its...
|Recent Actions by Supreme Court and U.S. Antitrust Authorities Illustrate Continued Focus on Antitrust Issues in the Health Care Sector|
Andrew J. Forman, Nandu Machiraju, Brian T. McGovern, Dean Shaffer; Cadwalader, Wickersham & Taft LLP;
December 18, 2012, previously published on December 12, 2012A few developments in the past month by the Supreme Court and the U.S. antitrust agencies serve as reminders that regulators continue to focus on antitrust enforcement in the health care sector. These recent actions, of course, are occurring during the health care reform process, which has spurred...